University of Newcastle

Explorance World 2024 Full Program Announced

Retrieved on: 
星期四, 五月 16, 2024
Technology, Human Resources, Other Technology, Professional Services, Software, Other Education, Data Analytics, Education, Artificial Intelligence, QC, Faculty, Human, Organization, WSJ, Blue, Business, Human resources, University, L&D, TIME, Workforce, University of Newcastle, Qualitative analysis, Higher education, Learning, CHRO, Student, AI, Research, MLY, Olympic, Associate, Sheridan College, Training, Organizational culture, Generative, GE HealthCare, Workplace, Synthetic media, Empowerment, Management

Explorance is unveiling today the full program for Explorance World 2024 , marking a significant milestone as the first-ever Explorance World event and the premier gathering of its kind in Montreal, where Explorance headquarters are located.

Key Points: 
  • Explorance is unveiling today the full program for Explorance World 2024 , marking a significant milestone as the first-ever Explorance World event and the premier gathering of its kind in Montreal, where Explorance headquarters are located.
  • Explorance World 2024, themed “Feedback for the Brave: Where Feedback Analytics Meets AI,” will provide attendees with exclusive insights into the latest trends, strategies, and technologies that are shaping the future of Feedback Analytics.
  • "Bringing the conference to Montreal fills me with genuine excitement," says Samer Saab, Founder and CEO of Explorance.
  • Explorance World 2024, sponsored by Tourisme Montreal, will take place from June 25th to June 28th, 2024, at The Westin Montreal, located at 270 Rue Saint-Antoine West, Montréal, QC H2Y 0A3, Canada.

Job Research Foundation Announces 2024 Grant Recipient

Retrieved on: 
星期二, 三月 12, 2024
Boston Children's Hospital, University of Pennsylvania, Disease, University of Freiburg, Associate, Patient, Hyperimmunoglobulin E syndrome, Research, Gene editing, Rockefeller University, Columbia University, University, Hospital, Aarhus University, Multimedia, University of Newcastle, Barber–Say syndrome, Pharmaceutical industry

NEW YORK, March 12, 2024 /PRNewswire/ -- The Job Research Foundation was established to underwrite research into Job Syndrome, also known as Autosomal Dominant Hyperimmunoglobulin E Syndrome (AD-HIES), a rare multisystem immunodeficiency disorder.

Key Points: 
  • NEW YORK, March 12, 2024 /PRNewswire/ -- The Job Research Foundation was established to underwrite research into Job Syndrome, also known as Autosomal Dominant Hyperimmunoglobulin E Syndrome (AD-HIES), a rare multisystem immunodeficiency disorder.
  • This year's recipient, Dr. Rasmus O. Bak, Associate Professor at Aarhus University in Denmark, will receive a grant totaling $200,000.
  • Since 2019 the Job Research Foundation has funded a total of 15 scientific research projects.
  • The Job Research Foundation will start accepting the next round of grant applications in July 2024.

Noster research: NOSTER and Science Microbiome Prize Symposium and Award Ceremony Honor Young Researchers' Novel Contributions

Retrieved on: 
星期四, 十月 26, 2023
Research, Sport, University of Newcastle, Health, Shosei-en Garden, Max Planck Institute for Biology, Max Planck Institute for Developmental Biology, 1916 American Grand Prize, AAAS, Chair, University of Pennsylvania, Drug development, Fellow of the American Association for the Advancement of Science, Disease, Higashi Hongan-ji, Partnership, University, Max Planck Society, Managing editor, Prize, Pharmaceutical industry, Physiology, Science, Medicine

KYOTO, Japan, Oct. 26, 2023 /PRNewswire/ -- NOSTER Inc and Science, the prestigious academic journal, joined forces to host the NOSTER and Science Microbiome Prize Symposium and the 4th prize award ceremony on October 5th and 6th in Kyoto, Japan.

Key Points: 
  • KYOTO, Japan, Oct. 26, 2023 /PRNewswire/ -- NOSTER Inc and Science, the prestigious academic journal, joined forces to host the NOSTER and Science Microbiome Prize Symposium and the 4th prize award ceremony on October 5th and 6th in Kyoto, Japan.
  • The NOSTER & Science Microbiome Prize rewards innovative research from young investigators studying how microbiota has the potential to contribute to our understanding of health and disease, or to guide novel therapeutic interventions.
  • The Japanese company NOSTER established this award in 2020 in partnership with Science and its publisher, the American Association for the Advancement of Science (AAAS).
  • NOSTER remains committed to supporting young scientists through this award and aims to contribute to breakthrough drug development driven by microbiome research.

Noster research: NOSTER and Science Microbiome Prize Symposium and Award Ceremony Honor Young Researchers' Novel Contributions

Retrieved on: 
星期四, 十月 26, 2023
Research, Sport, University of Newcastle, Health, Shosei-en Garden, Max Planck Institute for Biology, Max Planck Institute for Developmental Biology, 1916 American Grand Prize, AAAS, Chair, University of Pennsylvania, Drug development, Fellow of the American Association for the Advancement of Science, Disease, Higashi Hongan-ji, Partnership, University, Max Planck Society, Managing editor, Prize, Pharmaceutical industry, Physiology, Science, Medicine

KYOTO, Japan, Oct. 26, 2023 /PRNewswire/ -- NOSTER Inc and Science, the prestigious academic journal, joined forces to host the NOSTER and Science Microbiome Prize Symposium and the 4th prize award ceremony on October 5th and 6th in Kyoto, Japan.

Key Points: 
  • KYOTO, Japan, Oct. 26, 2023 /PRNewswire/ -- NOSTER Inc and Science, the prestigious academic journal, joined forces to host the NOSTER and Science Microbiome Prize Symposium and the 4th prize award ceremony on October 5th and 6th in Kyoto, Japan.
  • The NOSTER & Science Microbiome Prize rewards innovative research from young investigators studying how microbiota has the potential to contribute to our understanding of health and disease, or to guide novel therapeutic interventions.
  • The Japanese company NOSTER established this award in 2020 in partnership with Science and its publisher, the American Association for the Advancement of Science (AAAS).
  • NOSTER remains committed to supporting young scientists through this award and aims to contribute to breakthrough drug development driven by microbiome research.

InterAx Biotech Announces the Appointment of Seasoned Pharmaceutical Executive, Mark Levick, MD, Ph.D. as New Board Director

Retrieved on: 
星期二, 十月 3, 2023
Research, Technology, Genetics, Health Technology, Software, Biotechnology, Pharmaceutical, Health, Science, Artificial Intelligence, Faculty, GSK, Royal college, University, Drug development, Senior, Tropical medicine, G protein-coupled receptor, Levick, University of Cambridge, Membership of the Royal College of Physicians of Ireland, Cancer, ETH Zurich, Faculty of Pharmaceutical Medicine, Multimedia, Biomarker, Computational chemistry, Doctor of Philosophy, Language, Paul Scherrer Institute, GPCR, Novartis, MD, Vivo, Drug discovery, Commonwealth Scholarship and Fellowship Plan, Artificial intelligence, Marie Cassidy, FRCPA, University of Newcastle, Pharmaceutical medicine, Pharmacology, Medical device, Pharmaceutical industry, EU, Physician, AI

InterAx Biotech AG, a product development company pioneering computational pharmacology for creating breakthrough therapies, announces the appointment of Dr. Mark Levick to the board of directors.

Key Points: 
  • InterAx Biotech AG, a product development company pioneering computational pharmacology for creating breakthrough therapies, announces the appointment of Dr. Mark Levick to the board of directors.
  • View the full release here: https://www.businesswire.com/news/home/20231003682932/en/
    Dr. Mark Levick, MD, Newly appointed Board Director of InterAx Biotech (Photo: Business Wire)
    Mark Levick is the former CEO of Alvotech, a global biopharmaceutical company listed on the US NASDAQ.
  • In addition to building the company’s pipeline, Mark and his team led the approval and commercial launch of Simlandi/Hukyndra in 17 countries.
  • Mark has received several awards and authored peer-reviewed papers in the fields of tropical medicine, vaccine immunology and drug development.

Introducing our new series on the future of Australian higher education

Retrieved on: 
星期六, 四月 15, 2023
Government, Reality Bites, Coffee, University, Knowledge, The Conversation, Reality, Accord, Chancellor, Student, University of Newcastle, Education, Research, Management, Nursing

The Australian Universities Accord is a grandly named 12-month review seeking ideas to reform Australia’s higher education system for the next 30 years.

Key Points: 
  • The Australian Universities Accord is a grandly named 12-month review seeking ideas to reform Australia’s higher education system for the next 30 years.
  • It’s hard not to be a bit cynical about something billed as a “once-in-a-generation opportunity” for a “visionary plan”.
  • But a government that doesn’t try to grapple with the big picture is certain to fail, and higher education is vital to Australia’s future.
  • Comments will be open and moderated on all the articles in the series, so you can be part of an important discussion about the role of higher education in our shared future.

Lanier Biotherapeutics to Present Seminal LNR125 Publication at American Thoracic Society Meeting

Retrieved on: 
星期五, 五月 13, 2022
Rhinovirus, Inflammation, Allergy, Damage-associated molecular pattern, Retina, Asthma, Dermatology, LNR, Associate, Nature Communications, Mouse, University, University of Newcastle, GLOBE, Vaccine

LNR125 is a first-in-class inhibitor of the Alarmin IL-25, an upstream epithelial cytokine that mediates Type 2 inflammation and is implicated in different atopic, allergic and inflammatory diseases.

Key Points: 
  • LNR125 is a first-in-class inhibitor of the Alarmin IL-25, an upstream epithelial cytokine that mediates Type 2 inflammation and is implicated in different atopic, allergic and inflammatory diseases.
  • We are excited to present this seminal paper, which describes LNR125s ability to both inhibit allergic airway inflammation and augment anti-viral immunity, said Dr. Nathan Bartlett, Ph.D., Associate Professor/Head of Viral Immunology and Respiratory Disease group, University of Newcastle, Australia.
  • We demonstrated that LNR125 augments anti-viral immunity in rhinovirus-infected human asthmatic bronchial epithelial cells, as well as coronavirus-infected human bronchial epithelial cells.
  • We also showed that LNR125 boosted anti-viral immunity and reduced both lung viral load and airway inflammation in mice exposed to both rhinovirus and an allergen.

Proactive news headlines including Australian Vanadium, Latin Resources, Azure Minerals and Race Oncology

Retrieved on: 
星期三, 三月 16, 2022
Lithium, CRR, Biophysical environment, Proactivity, ASX, Federation, OTCQB, University of Newcastle, Central, Ridge, Acquisition, DSF Refractories & Minerals Ltd, Federal, KTA, AON, Zinc, Urana, ESG, Social, Kidney cancer, OTC, LRS, Product Licence Number, Program, University, AVL, SSH, RAC, TSC, Copper, CPH, DUN, Tin, TEG, 2012 Australian federal budget, Associate, GLOBE, SNS, La Luz Silver Project, NSW, Hunter Medical Research Institute, AAA, Gold, Uranium, Renewable energy, Mining, Crux, Central Africa

Click here

Key Points: 
  • Click here
    Arafura Resources Ltd (ASX:ARU) has picked up $30 million under the Federal Governments Modern Manufacturing Initiative and shares are trading higher.
  • Click here
    Dundas Minerals Ltd (ASX:DUN) has pinpointed a series of highly conductive anomalies at its wholly-owned Central nickel-copper target in WAs Albany-Fraser Orogen.
  • Proactive has produced over 300,000 articles and 20,000 executive interviews since it was established in 2006.
  • For more information on how Proactive can help you make a difference, email us at [email protected]

Nihon University Taps Penetron for New Overseas Campus in Australia

Retrieved on: 
星期四, 三月 10, 2022
University, Coal, Research, Groundwater, Pacific coast, Penetron, Boral, University of Newcastle, Group, Solution, Climate, Domestic international sales corporation, Nihon University, Student, Permeability, Grout, Curriculum, Tunnel

EAST SETAUKET, N.Y., March 10, 2022 /PRNewswire-PRWeb/ -- Tokyo-based Nihon University welcomed the first students to its new international campus in Newcastle, Australia in January 2022.

Key Points: 
  • EAST SETAUKET, N.Y., March 10, 2022 /PRNewswire-PRWeb/ -- Tokyo-based Nihon University welcomed the first students to its new international campus in Newcastle, Australia in January 2022.
  • PENETRON ADMIX , a crystalline waterproofing admixture, was specified to protect the new concrete structures from high groundwater levels and the climate.
  • With over 70,000 students, Nihon University is the largest private educational institution in Japan.
  • Originally founded in 1189 as the Nihon Law School, the University now comprises 16 colleges, 20 postgraduate schools, and 32 research institutes.

Proactive news headlines including Antilles Gold, Suvo Strategic Minerals, Sovereign Metals and Azure Minerals

Retrieved on: 
星期四, 三月 10, 2022
Well, Lithium, University, Curtin University, Mineral, AAU, Gold, MEK, OTCQB, Ciego de Ávila, PLL, PEA, ASX, Growth, Program, Yilgarn Craton, GTR, PEC, Hunter Medical Research Institute, HRM, GLOBE, KTA, SVM, RC, NASDAQ, Cuban, AOI, AIM, RAC, Piedmont Lithium, Proactivity, Pegasus, DSF Refractories & Minerals Ltd, La, Mining, Kidney cancer, University of Newcastle, Associate, Risk management, Uranium, Oil, Mulga Bill's Bicycle

Click here

Key Points: 
  • Click here
    Sovereign Metals Ltd (ASX:SVM, AIM:SVML) is now a member of the UKs Critical Minerals Association, an organisation that works to increase the self-sufficiency of supply chains to bolster the UKs industrial strategy.
  • Click here
    Azure Minerals Ltd (ASX:AZS) has completed its maiden reverse circulation (RC) drilling program at the Barton Gold Project situated within the Kookynie Gold District of Western Australia.
  • Proactive has produced over 300,000 articles and 20,000 executive interviews since it was established in 2006.
  • For more information on how Proactive can help you make a difference, email us at [email protected]